An optimized and validated 384-well plate assay to test platelet function in a high-throughput screening format

References

• McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol. 2018;15:181–191. doi:10.1038/nrcardio.2017.206
   PubMed Web of Science ®Google Scholar
• Fitzmaurice DA, Blann AD, Lip GY. Bleeding risks of antithrombotic therapy. BMJ. 2002;325(7368):828–831.
   PubMed Web of Science ®Google Scholar
• Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011;162(6):1239–1249. doi:10.1111/j.1476-5381.2010.01127.x
   PubMed Web of Science ®Google Scholar
• Ek B, Fb M. State of the art in platelet function testing. Transfus Med Hemother. 2013;40(2):73–86. doi:10.1159/000350469
   PubMed Web of Science ®Google Scholar
• Dockendorff C, Aisiku O, Verplank L, Dilks JR, Smith DA, Gunnink SF, Dowal L, Negri J, Palmer M, Macpherson L, et al. Discovery of 1,3-diaminobenzenes as selective inhibitors of platelet activation at the PAR1 receptor. ACS Med Chem Lett. 2012;3(3):232–237. doi:10.1021/ml2002696
   PubMed Web of Science ®Google Scholar
• VerPlank L., Dockendorff, C., Negri, J., Perez, J.R., Dilks, J.,MacPherson, L., Palmer, M., Flaumenhaft, R., Schreiber, S.L.Chemical genetic analysis of platelet granule secretion-probe 1. Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD). 2010.
   Google Scholar
• VerPlank L., Dockendorff, C., Negri, J., Perez, J.R., Dilks, J.,MacPherson, L., Palmer, M., Flaumenhaft, R., Schreiber, S.L. Chemical genetic analysis of platelet granule secretion-probe 3. Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD). 2010.
   Google Scholar
• Sim DS, Merrill-Skoloff G, Furie BC, Furie B, Flaumenhaft R. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood. 2004;103(6):2127–2134. doi:10.1182/blood-2003-04-1133
   PubMed Web of Science ®Google Scholar
• Selnick HG, Barrow JC, Nantermet PG, Connolly TM. Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1. Curr Med Chem Cardiovasc Hematol Agents. 2003;1(1):47–59.
   PubMedGoogle Scholar
• Taylor L, Vasudevan SR, Jones CI, Gibbins JM, Churchill GC, Campbell RD, Coxon CH, Ahrens I. Discovery of novel GPVI receptor antagonists by structure-based repurposing. PLoS One. 2014;9(6):e101209. doi:10.1371/journal.pone.0101209
   PubMed Web of Science ®Google Scholar
• Young SE, Duvernay MT, Schulte ML, Lindsley CW, Hamm HE. Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human platelets. PLoS One. 2013;8(6):e65528. doi:10.1371/journal.pone.0065528
   PubMed Web of Science ®Google Scholar
• Chan MV, Knowles RB, Lundberg MH, Tucker AT, Mohamed NA, Kirkby NS, Armstrong PC, Mitchell JA, Warner TD. P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation. Br J Clin Pharmacol. 2016;81(4):621–633. doi:10.1111/bcp.12736
   PubMed Web of Science ®Google Scholar
• Lima AM, Wegner SV, Martins Cavaco AC, Estevão-Costa MI, Sanz-Soler R, Niland S, Nosov G, Klingauf J, Spatz JP, Eble JA. The spatial molecular pattern of integrin recognition sites and their immobilization to colloidal nanobeads determine α2β1 integrin-dependent platelet activation. Biomaterials. 2018;167:107–120. doi:10.1016/j.biomaterials.2018.03.028
   PubMed Web of Science ®Google Scholar
• Chan MV, Armstrong PC, Warner TD. 96-well plate-based aggregometry. Platelets. 2018;15:1–6(Epub ahead of print).
   Google Scholar
• Ridler TW, Calvard S. Picture thresholding using an iterative selection method. IEEE Trans Syst Cybernetics. 1978;8(8):630–632.
   Web of Science ®Google Scholar
• Jh Z, Td C, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4(2):67–73. doi:10.1177/108705719900400206
   PubMedGoogle Scholar
• Iversen P.W., Beck, B., Chen, Y.-F., Dere, W.,Devanarayan, V., Eastwood, B.J., Farmen, M.W., Iturria, S.J.,Montrose, C., Moore, R.A., et al. HTS Assay Validation. In: Sittampalam GS, Coussens NP, Brimacombe K, Grossman, A., Arkin, M., Auld, D., Austin,C., Baell, J., Bejcek, B., Caaveiro, J.M.M., editors. Assay Guidance Manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004.
   Google Scholar
• Jabs CM, Ferrell WJ, Robb HJ. Plasma ADP levels: direct determination with luciferase luminescence using a biometer. Clin Biochem. 1978;11(5):190–193.
   PubMed Web of Science ®Google Scholar
• Sun B, Tandon NN, Yamamoto N, Yoshitake M, Kambayashi J. Luminometric assay of platelet activation in 96-well microplate. Biotechniques. 2001;31(5):1174,6, 8 passim.
   Web of Science ®Google Scholar
• Zhang JH, Oldenburg KR. Z-factor. New York: Springer; 2008. Available from http://rave.ohiolink.edu/ebooks/ebc/9783540476481
   Google Scholar
• Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927–929.
   PubMed Web of Science ®Google Scholar
• Fratantoni JC, Poindexter BJ. Measuring platelet aggregation with microplate reader. A new technical approach to platelet aggregation studies. Am J Clin Pathol. 1990;94(5):613–617.
   PubMed Web of Science ®Google Scholar
• Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate- receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657–666.
   PubMed Web of Science ®Google Scholar
• Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102(5):1701–1707. doi:10.1182/blood-2003-03-0717
   PubMed Web of Science ®Google Scholar
• Truss NJ, Armstrong PCJ, Liverani E, Vojnovic I, Warner TD. Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods. J Thromb Haemost. 2009 Nov;7(11):1897–1905. doi:10.1111/j.1538-7836.2009.03589.x
   PubMed Web of Science ®Google Scholar
• Wallén NH, Ladjevardi M, Albert J, Bröijersén A. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular Mass Heparin and Hirudin. Thromb Res. 1997 Jul;87(1):151–157. doi:10.1016/S0049-3848(97)00114-X
   PubMed Web of Science ®Google Scholar
• Kingston JK, Bayly WM, Sellon DC, Meyers KM, Wardrop KJ. Effects of sodium citrate, low molecular weight heparin, and prostaglandin E1 on aggregation, fibrinogen binding, and enumeration of equine platelets. Am J Vet Res. 2001 Apr;62(4):547–554.
   PubMed Web of Science ®Google Scholar